Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
This is an interventional, parallel arm assignment treatment study in individuals with
Major Depressive Disorder (MDD). Each individual will be treated with a single dose of
pimavanserin or placebo plus a single dose of psilocybin. Evaluations will be taken
before do...
Age: 21 - 80 years
Gender: All
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
The proposed study is a single-site, randomized, controlled clinical trial (RCT)
comparing ketamine-assisted psychotherapy (KAP) to a standard evidence-based regimen of
ketamine administered in a medical model without psychotherapy (KET). Eligible study
participants ...
Age: 18 - 90 years
Gender: All
Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
The purpose of this study is to evaluate the long-term safety and tolerability of
BHV-7000, in participants with Major Depressive Disorder (MDD).
Age: 18 - 75 years
Gender: All
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
The goal of this clinical trial is to evaluate the effectiveness and safety of bilateral
stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain
Stimulation (DBS) as an adjunctive treatment of non-psychotic unipolar Major Depressive
Disorder (M...
Age: 22 - 70 years
Gender: All
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
The purpose of this study is to determine the efficacy and safety of BHV-7000 in
participants with Major Depressive Disorder (MDD)
Age: 18 - 75 years
Gender: All
Neural Circuit Effects of Ketamine in Depression
This project is designed to examine the role of the subgenual anterior cingulate cortex (sgACC) in anhedonia and anxiety in humans with depression, as well as the acute and sustained effects of ketamine on agACC activation and depression symptoms.
Age: 18 - 65 years
Gender: All
DBS for TRD with the Medtronic Percept PC
Of the estimated 30 million Americans who suffer from Major Depressive Disorder,
approximately 10% are considered treatment resistant. Deep brain stimulation (DBS) to a
region of the brain called the subcallosal cingulate (SCC) is an emerging strategy for
treatment r...
Age: 25 - 70 years
Gender: All
Invasive Decoding and Stimulation of Altered Reward Computations in Depression
Novel invasive neurostimulation stimulation strategies through neurosurgical
interventions are emerging as a promising therapeutical strategy for major depressive
disorder. These have been applied mostly to the anterior cingulate cortex, but other
limbic brain region...
Age: 18 - 80 years
Gender: All
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Objectives of this study are to determine whether active VNS Therapy treatment is
superior to a no stimulation control in producing a reduction in baseline depressive
symptom severity, based on multiple depression scale assessment tools at 12 months from
randomizatio...
Age: 18 years - 66+
Gender: All